<http://linked.opendata.cz/resource/sukl/spc/sentence/SPC158715_doc-4-5-20-2>	<http://salt.semanticauthoring.org/ontologies/sdo#hasStartPointer>	"14569"^^<http://www.w3.org/2001/XMLSchema#long> .
<http://linked.opendata.cz/resource/sukl/spc/sentence/SPC158715_doc-4-5-20-2>	<http://salt.semanticauthoring.org/ontologies/sdo#hasEndPointer>	"14838"^^<http://www.w3.org/2001/XMLSchema#long> .
<http://linked.opendata.cz/resource/sukl/spc/sentence/SPC158715_doc-4-5-20-2>	<http://salt.semanticauthoring.org/ontologies/sdo#hasTextChunk>	<http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC158715_doc-4-5-20-2-14700-14718> .
<http://linked.opendata.cz/resource/sukl/spc/sentence/SPC158715_doc-4-5-20-2>	<http://salt.semanticauthoring.org/ontologies/sdo#hasTextChunk>	<http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC158715_doc-4-5-20-2-14658-14668> .
<http://linked.opendata.cz/resource/sukl/spc/sentence/SPC158715_doc-4-5-20-2>	<http://salt.semanticauthoring.org/ontologies/sdo#hasTextChunk>	<http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC158715_doc-4-5-20-2-14776-14786> .
<http://linked.opendata.cz/resource/sukl/spc/sentence/SPC158715_doc-4-5-20-2>	<http://salt.semanticauthoring.org/ontologies/sdo#hasText>	"Nebyly pozorov\u00E1ny \u017E\u00E1dn\u00E9 v\u00FDznamn\u00E9 farmakokinetick\u00E9 nebo farmakodynamick\u00E9 interakce byl-li irbesartan pod\u00E1v\u00E1n sou\u010Dasn\u011B s warfarinem, l\u00E9\u010Div\u00FDm p\u0159\u00EDpravkem metabolizovan\u00FDm CYP2C9. \u00DA\u010Dinky induktor\u016F CYP2C9, jako je rifampicin, na farmakokinetiku irbesartanu nebyly vyhodnoceny."@cs .
<http://linked.opendata.cz/resource/sukl/spc/sentence/SPC158715_doc-4-5-20-2>	<http://salt.semanticauthoring.org/ontologies/sdo#hasOrderNumber>	"2"^^<http://www.w3.org/2001/XMLSchema#int> .
<http://linked.opendata.cz/resource/sukl/spc/sentence/SPC158715_doc-4-5-20-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://salt.semanticauthoring.org/ontologies/sdo#Sentence> .